Press Release | Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis
April 10, 2020
Adelaide, Australia – Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance Clinical clients during this difficult time. Avance Clinical is a medium-sized full-service CRO known for its nimble and collaborative approach, with […]
Australia – Leading
Australian CRO Avance Clinical said there was still strong demand from Asian
and US sponsors, and commended Australian sites that had risen to the challenge
to deliver for Avance Clinical clients during this difficult time.
Avance Clinical is a medium-sized
full-service CRO known for its nimble and collaborative approach, with more
than 20-years of experience in managing early phase trials.
Avance Clinical’s Chief Strategist Ben
Edwards said a key factor in sponsor demand is the speed and attractive cost of
running trials in Australia. In particular, they include:
Australian Government financial rebate of more than 40% on clinical trial
required for clinical trials and streamlined regulatory processes
medical, research and scientific community, leading investigators and
KOLs, and modern medical facilities
Avance Clinical CEO Yvonne
Lungershausen, who has a background in pure research, said sponsors saw the
value of running studies in Australia.
“In addition, Australia is not as hard
hit by the COVID-19 crisis which has meant we can work with sites to deliver
studies that might otherwise be put on hold, costing time and money and causing
crippling delays to drug pipelines,” said Ms Lungershausen.
“We are pleased to be the Australian
CRO of choice for international sponsors,” she said.
“Australia’s reputation for FDA
compliant scientific and research excellence, its advanced healthcare, and the
opportunity to access patients in a less clinical trial competitive environment
further reinforces its advantage as a destination for clinical trials.”
Clinical has more than 20-years of experience and is now one of Australia’s
leading Contract Research Organisations. Avance Clinical facilitates quality
drug development by aligning people, skills, and expertise in the pursuit of
drug development for a healthier world.
Clinical is committed to providing high-quality clinical research services with
its highly-experienced team.
collective pool of knowledge and experience at Avance Clinical continually
grows through the careful selection of experts who also demonstrate passion in
their chosen field.
Clinical offers high quality services in an established clinical trial ecosystem,
that includes world-class Investigators and Sites able to access specialised
patient groups. Other benefits include:
The Government R&D grant means more than 40% rebate on clinical trial spend
Telehealth pivot during COVID-19 pandemic – speed and continuity
Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks
No IND required for clinical trials
Full GMP material is not mandated for Phase I clinical trials
Established clinical trial environment with world-class Investigators and sites
Established healthy subject databases and specialised patient populations
Five independent Phase 1 facilities across Australia including hospital-based units for critical care
Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research
Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia’s counter-flu and allergy seasons